TD Ameritrade Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,952
Closed -$228K 176
2023
Q2
$228K Sell
2,952
-561
-16% -$44.7K ﹤0.01% 159
2023
Q1
$291K Sell
3,513
-703
-17% -$58.2K ﹤0.01% 150
2022
Q4
$362K Sell
4,216
-1,101
-21% -$87.2K ﹤0.01% 154
2022
Q3
$328K Sell
5,317
-1,137
-18% -$71.7K ﹤0.01% 167
2022
Q2
$399K Sell
6,454
-5,261
-45% -$326K ﹤0.01% 180
2022
Q1
$696K Buy
11,715
+571
+5% +$36.5K 0.01% 158
2021
Q4
$809K Buy
11,144
+3,551
+47% +$245K 0.01% 141
2021
Q3
$480K Buy
7,593
+4,470
+143% +$314K ﹤0.01% 158
2021
Q2
$215K Buy
3,123
+482
+18% +$32.2K ﹤0.01% 231
2021
Q1
$154K Hold
2,641
﹤0.01% 235
2020
Q4
$154K Sell
2,641
-4,952
-65% -$299K ﹤0.01% 235
2020
Q3
$480K Sell
7,593
-497
-6% -$34.5K ﹤0.01% 158
2020
Q2
$622K Sell
8,090
-930
-10% -$71.3K 0.01% 145
2020
Q1
$674K Buy
9,020
+80
+0.9% +$5.53K 0.01% 140
2019
Q4
$581K Buy
8,940
+1,636
+22% +$107K ﹤0.01% 161
2019
Q3
$463K Buy
7,304
+2,030
+38% +$133K ﹤0.01% 164
2019
Q2
$356K Buy
5,274
+1,332
+34% +$87.6K ﹤0.01% 166
2019
Q1
$256K Buy
3,942
+933
+31% +$62K ﹤0.01% 173
2018
Q4
$188K Buy
3,009
+2,029
+207% +$142K ﹤0.01% 161
2018
Q3
$76K Buy
+980
New +$74K ﹤0.01% 192

Other funds holding GILD

TD Ameritrade Investment Management's GILD Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of Gilead Sciences (GILD) in Q3 2023, closing a stake of 2,952 shares — an estimated $228K sold.

TD Ameritrade Investment Management first reported a position in GILD in Q3 2018 and held it in 20 quarters. The position peaked at $809K in Q4 2021. 1,682 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • TD Ameritrade Investment Management reported no remaining Gilead Sciences position as of Q3 2023 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 2,952 Gilead Sciences shares in Q3 2023, an estimated $228K.
  • TD Ameritrade Investment Management first reported a position in Gilead Sciences in Q3 2018 and held it in 20 quarters.
  • TD Ameritrade Investment Management's Gilead Sciences position peaked at $809K in Q4 2021.
  • 1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.